Talk:α-Hydroxyetizolam

From WikiProjectMed
Jump to navigation Jump to search

Naming of the article

Most of the scientific references are showing this compound as alpha-Hydropxyetizolam. If this is the true form, then a "move" can be executed. -Hatchens (talk) 07:34, 23 February 2021 (UTC)[reply]

Requested move 23 February 2021

The following is a closed discussion of a requested move. Please do not modify it. Subsequent comments should be made in a new section on the talk page. Editors desiring to contest the closing decision should consider a move review after discussing it on the closer's talk page. No further edits should be made to this discussion.

The result of the move request was: Moved to correct mis-spelling. Polyamorph (talk) 19:38, 10 March 2021 (UTC) (non-admin closure)[reply]


Alpha-Hydropxyetizolam → alpha-hydroxyetizolam – Incorrect name was specified in some of the cited research papers, however the true name as per pubchem and MESH is alpha-hydroxyetizolam[1][2]

References

  1. ^ https://pubchem.ncbi.nlm.nih.gov/compound/15135972#section=Transformations&fullscreen=true
  2. ^ https://www.ncbi.nlm.nih.gov/mesh/67069801
Daszabo (talk) 12:33, 23 February 2021 (UTC)[reply]
  • Support per nom. Redirect from the "common mis-spelling" solves the problem of readers finding it if they have seen it in those typo'd papers. DMacks (talk) 14:56, 24 February 2021 (UTC)[reply]
  • Support this alternative. The p in Hydropxyetizolam appears to be as stated a typo which has spread to the literature but is not (fortunately) common enough to warrant more than a redirect. But the capital H is per the official naming convention. Andrewa (talk) 17:19, 3 March 2021 (UTC)[reply]
The discussion above is closed. Please do not modify it. Subsequent comments should be made on the appropriate discussion page. No further edits should be made to this discussion.

Requested move 10 June 2023

The following is a closed discussion of a requested move. Please do not modify it. Subsequent comments should be made in a new section on the talk page. Editors desiring to contest the closing decision should consider a move review after discussing it on the closer's talk page. No further edits should be made to this discussion.

The result of the move request was: Moved. (non-admin closure) SilverLocust (talk) 21:02, 27 June 2023 (UTC)[reply]

Alpha-Hydroxyetizolam → Α-Hydroxyetizolam – The page name should use a capital Greek alpha in order to use {{lowercasetitle}} to display the title correctly as α-Hydroxyetizolam per WP:CHEMPREFIX. Normally I would execute this move boldly per CHEMPREFIX, but a requested move is in order due to the previous (and relatively recent) RM discussion above, per WP:PCM. Mdewman6 (talk) 22:57, 10 June 2023 (UTC) — Relisting. CLYDE TALK TO ME/STUFF DONE (please mention me on reply) 01:05, 18 June 2023 (UTC)[reply]

The discussion above is closed. Please do not modify it. Subsequent comments should be made on the appropriate discussion page. No further edits should be made to this discussion.
Retrieved from "https://mdwiki.org/wiki/Talk:Α-Hydroxyetizolam"